# Dacarbazine

NDC: 0143-9245
Generic name: Dacarbazine
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20010808

FDA application: ANDA075812

## Active ingredients

- DACARBAZINE: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0143-9245"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0143-9245
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0d81315c-7021-4091-b703-ad135390c936